<DOC>
	<DOCNO>NCT01917942</DOCNO>
	<brief_summary>This two arm randomise phase III trial evaluate prospectively benefit humidification patient receive radiotherapy / chemoradiation head neck cancer . The intent humidification moisturise mucosa . The rationale use humidification radiotherapy consider extension general principle moist wound care wound management .</brief_summary>
	<brief_title>Radiotherapy With Humidification Head And Neck Cancer</brief_title>
	<detailed_description>This phase III trial address four hypothesis . The primary hypothesis : Humidification modulate natural history mucositis result clinically significant reduction intensity severe acute mucositis function time CTCAE grade &gt; 1 mucositis ( e.g . grade 2 high ) , measure area time curve ( AUC ) plot express grade acute reaction vs week observe CTCAE mucosal reaction &gt; 1 The additional hypothesis : - Humidification palliate acute symptom mucositis xerostomia - Humidification cost effective reduction hospital bed occupancy - Humidification improve functional outcome , particularly swallow function , patient head neck cancer treat radiotherapy</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Patients meet follow criterion eligible : Pathologically confirm diagnosis cancer involve Nasopharynx , Oropharynx , Oral Cavity , Larynx , Hypopharynx Regional nodal irradiation include PTV1 ( minimum ipsilateral level IIIII ) Prescribed dose radiotherapy least 60 Gy Receiving definitive postoperative adjuvant Radiotherapy Receiving Radiotherapy sole modality Chemoradiation Patient &gt; 18 year old Available followup 2 year Life expectancy great 6 month Written inform consent Participation patient clinical trial protocol permit Patients meet follow criterion exclude : Presence tracheostomy stoma Diagnosis T1 / T2 glottic carcinoma Undergoing CPAP therapy Treatment Amifostine Palifermin ( keratinocyte growth factor ) radiotherapy History previous radiotherapy head neck region , exclude superficial radiotherapy cutaneous squamous cell carcinoma basal cell carcinoma High risk poor compliance radiotherapy , humidification , followup assess investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Humidification</keyword>
	<keyword>Mucositis</keyword>
</DOC>